NEB investigators are utilizing emerging methods and technologies to further their research, including:
Investigators are using metabolomic profiling to test associations between blood and urine metabolites and colon, pancreas, and breast cancers. This includes both agnostic assessments and evaluation of metabolomic biomarkers of exposures, such as diet, physical activity, and tobacco.
Investigators are conducting a colorectal cancer case-control analysis incorporating assessment of the fecal microbiome and fecal metabolomics.
Investigators are conducting a large, nested case-control study of the oral microbiome and cancer at multiple locations, including head and neck, esophagus, stomach, lung, pancreas, and colorectum.